Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Sarcoma Clinical Trials

104 recruiting trials for Sarcoma. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
104
Total Trials
104
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGPhase 1 / Phase 2NCT06710756

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Phase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation...

Sponsor: Perspective TherapeuticsEnrolling: 1123 locations
RECRUITINGPhase 1NCT06789172

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

The purpose of this study is to investigate the study drug, OKN4395, administered alone and in combination with pembrolizumab. The overall objectives of this study are to...

Sponsor: EpkinEnrolling: 16610 locations
RECRUITINGPhase 2NCT03935893

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

This is a Phase 2 study to evaluate the efficacy of a non-myeloablative lymphodepleting preparative regimen followed by infusion of autologous TIL and high-dose aldesleukin in...

Sponsor: Udai KammulaEnrolling: 2401 location
RECRUITINGPhase 1NCT05130255

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

Patients with Small Cell Lung Cancer, High Risk Neuroblastoma, Sarcoma and Malignant Melanoma will be treated with GD2-SADA:177Lu-DOTA complex(The IMP is a two-step...

Sponsor: Y-mAbs TherapeuticsEnrolling: 608 locations
RECRUITINGNCT07227961

PROMIS and Mobility Evaluation in Sarcoma Patients

The goal of this is to validate the Patient-Reported Outcomes Measurement Information System (PROMIS) in sarcoma patients undergoing surgery, and to evaluate a novel smartphone...

Sponsor: University of CalgaryEnrolling: 8004 locations
RECRUITINGPhase 2NCT06503146

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Background: Fibroblast-activation protein (FAP) is an enzyme that appears in high numbers in cancer-associated fibroblasts of certain cancer types. \[18F\]FAPI-74 is a new PET...

Sponsor: National Cancer Institute (NCI)Enrolling: 3201 location
RECRUITINGNCT02012699

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal...

Sponsor: University of NebraskaEnrolling: 99999920 locations
RECRUITINGNCT05835154

A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma

This trial tests how well the advanced care planning around mobility needs checklist tool works to assess future mobility needs in patients with sarcoma. Gathering information...

Sponsor: Fred Hutchinson Cancer CenterEnrolling: 201 location
RECRUITINGPhase 1NCT07121946

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

This study is a first-in-human (FIH), Phase 1, multicenter, open-label study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and evaluate the...

Sponsor: LTZ Therapeutics, Inc.Enrolling: 425 locations
RECRUITINGPhase 1NCT06957431

Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma

The investigators hypothesize that the combination of eribulin and zanzalintinib will be tolerable and lead to improved progression-free survival (PFS) as compared to eribulin...

Sponsor: Washington University School of MedicineEnrolling: 181 location
RECRUITINGNCT04219202

Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion

The study is a randomized, open, prospective phase II study. The aim of the study is to evaluate the safety and feasibility of a hypofractionated, accelerated radiation approach...

Sponsor: University Hospital HeidelbergEnrolling: 641 location
RECRUITINGNCT05653388

Metastatic Leiomyosarcoma Biomarker Protocol

Leiomyosarcoma (LMS) is one of the most prevalent soft tissue sarcomas (STS) and can occur in various sites including soft tissue, uterus and retroperitoneal large vessels....

Sponsor: University of Michigan Rogel Cancer CenterEnrolling: 20011 locations
RECRUITINGPhase 2NCT06158399

AZA Combined With RCHOP in P53-mutated DLBCL.

To evaluate the efficacy and adverse effects of Azacitidine in combination with R-CHOP (ARCHOP) for the treatment of TP53-mutated previously untreated Diffuse large B-cell lymphoma

Sponsor: The First Affiliated Hospital of Xiamen UniversityEnrolling: 521 location
RECRUITINGNCT07188532

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

This clinical trial evaluates the effect of radiotherapy doses based on tumor size and tumor-specific characteristics (biologically-adapted) in treating patients with Ewing...

Sponsor: Mayo ClinicEnrolling: 1411 location
RECRUITINGNCT07432932

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

This is a cohort study aimed at developing a stratified medicine approach for personalised neoadjuvant chemotherapy (NCT) in high-risk soft tissue sarcoma (STS) patients with...

Sponsor: Royal Marsden NHS Foundation TrustEnrolling: 8001 location
RECRUITINGNCT02789384

CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.

This is a prospective observational biomarker study including patients with non-metastatic, soft-tissue sarcomas (STS) for whom neoadjuvant chemotherapy is considered as the best...

Sponsor: Institut BergoniéEnrolling: 20510 locations
RECRUITINGNCT05978024

Predicting Radiotherapy Response and Toxicities in Soft Tissue Sarcoma of the Extremities - Cohort B

This is a multicentre prospective cohort study, primarily aimed at reporting the frequency and intensity of radiotherapy side-effects of patients with soft tissues sarcoma of the...

Sponsor: Royal Marsden NHS Foundation TrustEnrolling: 1503 locations
RECRUITINGNCT07062003

Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft...

This clinical trial tests the safety and best dose of minibeam radiation therapy (MBRT) with a tungsten slit collimator for treating patients with skin or soft tissue tumors that...

Sponsor: Mayo ClinicEnrolling: 601 location
RECRUITINGPhase 1 / Phase 2NCT05876715

LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma

This is an open label, dose-seeking phase 1/2 study using escalating doses of LURBINECTEDIN administered intravenously with fixed doses of IPILIMUMAB and NIVOLUMAB administered...

Sponsor: ERLINDA M GORDONEnrolling: 401 location
RECRUITINGPhase 1NCT06830031

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

This study is to investigate the safety and tolerability of C402-CD19-CAR treatment in subjects with relapsed or refractory large B-cell lymphoma and further determine the...

Sponsor: Shanghai Exuma Biotechnology Ltd.Enrolling: 181 location
RECRUITINGNCT06004011

AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)

Adolescents and young adults living with HIV experience higher premature mortality from cancer than their uninfected peers. In Zambia, because of multilevel barriers,...

Sponsor: ImplenomicsEnrolling: 41001 location
RECRUITINGNCT06526065

Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

The trial aims at the construction and validation of an accurate, affordable and simple prognostic tool to be used in everyday clinical practice, which allows the early and...

Sponsor: University Medical Center GoettingenEnrolling: 5001 location
RECRUITINGNCT06515860

Neurofibromatosis Type 1 Tumor Early Detection Study

The goal of this observational study is to determine if a liquid biopsy (i.e. blood test) is an effective clinical tool for monitoring the development of malignant peripheral...

Sponsor: David MillerEnrolling: 10001 location
RECRUITINGPhase 2NCT05500391

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the...

Sponsor: Centre Oscar LambretEnrolling: 883 locations
RECRUITINGNCT03175718

INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients

Project Summary - Aggressive soft tissue cancers are commonly treated with radiation followed by surgery. These wounds have a very high rate of wound complications and infection...

Sponsor: Dr. J. WerierEnrolling: 2912 locations
RECRUITINGEarly Phase 1NCT05851456

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue...

20 participants are expected to be enrolled for this open,Single-armed clinical trial to evaluate the safety and efficacy of the recombinant herpes simplex virus Ⅰ, R130 in...

Sponsor: Shanghai Yunying Medical TechnologyEnrolling: 201 location
RECRUITINGNCT06068075

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

This is a prospective multicenter biomarker study evaluating the prognostic impact of ctDNA detection at diagnosis in patients with Ewing sarcoma or osteosarcoma.

Sponsor: Dana-Farber Cancer InstituteEnrolling: 34015 locations
RECRUITINGPhase 1NCT06926283

A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors

This is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, MTD, DLT, RP2D, the PK characteristics, preliminary anti-tumor...

Sponsor: Hangzhou DAC Biotechnology Co., Ltd.Enrolling: 1103 locations
RECRUITINGPhase 1 / Phase 2NCT03138161

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

This is an open label, dose-seeking phase 1/2 study using escalating doses of TRABECTEDIN given intravenously with defined doses of IPILIMUMAB and NIVOLUMAB based on preliminary...

Sponsor: Sarcoma Oncology Research Center, LLCEnrolling: 2501 location
RECRUITINGPhase 1 / Phase 2NCT06395103

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid...

Substudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab vedotin in pediatric participants with relapsed or...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 9020 locations
RECRUITINGNCT06282237

Clinical Evaluation, Motor Performance and Quality of Life in Patients Affected by Soft Tissue Sarcomas, Undergoing...

The main aim of the study is evaluate quality of life and motor performance of patients with soft tissue sarcomas undergoing surgical treatment and post-operative rehabilitation...

Sponsor: Fondazione Policlinico Universitario Campus Bio-MedicoEnrolling: 131 location
RECRUITINGPhase 2NCT06445166

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Kaposi sarcoma (KS) lesions are initiated by endothelial cells infected with KS herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8). Lesion progression is driven by...

Sponsor: Washington University School of MedicineEnrolling: 251 location
RECRUITINGNCT03751566

Acupuncture as the Therapeutic Modalities of Acute Toxicity in the Radiotherapy of Head and Neck Tumors

The aim of the study is to evaluate the benefit of the acupuncture as healing modalities in the therapy of acute toxicity of radiotherapy.

Sponsor: Masaryk Memorial Cancer InstituteEnrolling: 601 location
RECRUITINGPhase 2NCT04589741

Toripalimab Combined With CAV/IE Regimen

The aim of this study was to investigate the efficacy and safety of CAV/IE chemotherapy combined with toripalimab versus CAV/IE chemotherapy alone in the treatment of patients...

Sponsor: Sun Yat-sen UniversityEnrolling: 2001 location
RECRUITINGPhase 1 / Phase 2NCT06709495

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in...

This research is being done to test a new drug called PEEL-224 in combination with two commercially available drugs, Vincristine and Temozolomide, and to determine how effective...

Sponsor: David S Shulman, MDEnrolling: 633 locations
RECRUITINGPhase 3NCT04031677

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high...

Sponsor: European Organisation for Research and Treatment of Cancer - EORTCEnrolling: 25020 locations
RECRUITINGPhase 2NCT06436612

Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic...

Recent advances in radiation treatment have allowed for higher doses per treatment to be delivered safely. This study plans to use an MRI-guided linear accelerator to deliver the...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 201 location
RECRUITINGNCT06408441

The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

Epithelioid hemangioendothelioma (EHE) is an ultra-rare sarcoma, marked by distinctive molecular and pathological features and with a variable clinical behavior. Its natural...

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoEnrolling: 10020 locations
RECRUITINGPhase 2NCT06637007

Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma

Evaluation of the efficacy and safety of Xidabenzamide combined with AK112 for advanced bone and soft tissue sarcoma of second-line and above.

Sponsor: Shanxi Province Cancer HospitalEnrolling: 301 location
RECRUITINGNCT04458792

Establishment of a Prospective Clinical-biological Database

A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical data to improve knowledge about cancer and help to...

Sponsor: Institut du Cancer de Montpellier - Val d'AurelleEnrolling: 4501 location
RECRUITINGPhase 1 / Phase 2NCT06465199

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

The purpose of this study is to evaluate the investigational oral drug AMXT 1501 in combination with oral eflornithine (DFMO). An investigational drug is one that has not been...

Sponsor: Milton S. Hershey Medical CenterEnrolling: 2896 locations
RECRUITINGPhase 2NCT06593899

The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities

For localized soft tissue sarcomas (STS) of the extremities, limb-sparing or conservative surgery with perioperative radiotherapy (RT) is the standard of care. However, several...

Sponsor: Fujian Medical University Union HospitalEnrolling: 511 location
RECRUITINGPhase 1NCT04715191

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid...

Patients may be considered if the cancer has come back, has not gone away after standard treatment or the patient cannot receive standard treatment. This research study uses...

Sponsor: Baylor College of MedicineEnrolling: 241 location
RECRUITINGPhase 2NCT04554914

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.

Sponsor: Pierre Fabre MedicamentEnrolling: 19020 locations
RECRUITINGNCT04990076

Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology

The main objective is to evaluate the diagnostic accuracy of the MUSA terms and definitions, as defined in the paper by Van den Bosch T, Dueholm M, ea. in 2015, to differentiate...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 15001 location
RECRUITINGPhase 2NCT05969860

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to...

Sponsor: Mayo ClinicEnrolling: 2202 locations
RECRUITINGNCT02677961

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the...

Sponsor: Ohio State University Comprehensive Cancer CenterEnrolling: 15001 location
RECRUITINGNCT06805773

Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic

This study aims to evaluate how sarcoma-specific educational videos improve patients' knowledge of their disease and treatment options before their first clinic appointment....

Sponsor: Mount Sinai Hospital, CanadaEnrolling: 1001 location
RECRUITINGPhase 2NCT04751409

Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in...

This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 2271 location
RECRUITINGPhase 1NCT05950802

Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta

This is a Phase 1b study of participants with Diffuse Large B Cell Lymphoma (DLBCL). The purpose of this study is to identify an optimized lymphodenpletion (LD) regimen by...

Sponsor: University Health Network, TorontoEnrolling: 401 location

Showing 50 of 104 trials.Search all Sarcoma trials